Video Lectures
State-of-the-industry video lectures by leading urology experts
Latest Videos

ORLANDO, FL USA (UroToday.com) - Dr. Michael Liss, a urologic oncology fellow at University of California-Irvine, presented his work evaluating the benefit of screening men with family history (FH) of prostate cancer. He was able to quantitate this benefit by post-hoc analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial patients, which randomized > 76,000 men to PSA-screening versus usual care. He first validated that the PLCO patients were going to be a valid population by showing that African American patients had a 2.6-fold increased odds ratio (OR) of prostate cancer-specific mortality (PCSM). 5,326 PLCO patients (7%) had a positive FH of prostate cancer. auaPatients with FH of prostate cancer who were also diagnosed with prostate cancer on average had lower PSA at diagnosis, more favorable Gleason score, and shorter time to diagnosis after entry into PLCO (all statistically significant) compared to those without FH of prostate cancer. There was a 50% reduction in PCSM, however this was not statistically significant (p=0.07).

He closed by suggesting that identification of high-risk patients based on clinical parameters might be augmented by novel biomarkers for further risk stratification.

Presented by Michael Liss at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

La Jolla, CA USA

Written by Philip Abbosh, MD, PhD, medical writer for UroToday.com

 

Calendar
Upcoming urology industry events
August 1-5, 2018 / Sheraton Philadelphia Society Hill Hotel
SUFU Research Foundation Resident Preceptorship 2018
August 3-4, 2018 / Hyatt Regency Washington on Capitol Hill
Best of ASCO 2018 - Washington, DC
August 10-11, 2018 / The Palmer House Hilton, Chicago, IL
Best of ASCO 2018 - Chicago, IL
August 28-31, 2018 / ICS 2018
International Continence Society 2018
Journals
Print publications focusing on urological cancer treatments through original commentary & articles
Everyday Urology Volume 2 Issue 4

Everyday Urology™ - Oncology Insights

From the Editor

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor